LGND Gross Margin

The Gross Margin of Ligand Pharmaceuticals Incorporated (LGND) is 74.78%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

LGND Gross Margin - Historical Value

Date	Value
2025-12-31	74.78%
2024-12-31	93.37%
2023-12-31	91.99%
2022-12-31	73.09%
2021-12-31	77.55%
2020-12-31	83.69%
2019-12-31	90.61%
2018-12-31	97.50%
2017-12-31	96.17%
2016-12-31	94.86%

LGND Gross Margin - Peers Comparison

Ticker	Name	Value
INO	Inovio Pharmaceuticals Inc	60.13%
PRLD	Prelude Therapeutics Incorporated	7775.20%
IMCR	Immunocore Holdings PLC	98.73%
KYMR	Kymera Therapeutics, Inc.	7775.20%
RUBY	Rubius Therapeutics Inc	7775.20%
950200.KQ	Psomagen Inc	24.48%
950220.KQ	Neoimmunetech Inc	7775.20%
ABBV	AbbVie Inc.	71.62%
MYOV	Myovant Sciences Ltd	77.68%
SWTX	SpringWorks Therapeutics, Inc.	93.45%
VRTX	Vertex Pharmaceuticals Incorporated	86.24%
ADCT	Adc Therapeutics Ltd	92.87%
DCPH	Deciphera Pharmaceuticals Inc	97.72%
FGEN	FibroGen Inc	47.47%
GBT	Global Blood Therapeutics Inc	98.30%
LEGN	Legend Biotech Corporation	60.34%
MCRB	Seres Therapeutics, Inc.	7775.20%
REGN	Regeneron Pharmaceuticals, Inc.	86.56%
VIE	Viela Bio Inc	82.49%
ALXO	ALX Oncology Holdings Inc	9.32%
AMGN	Amgen Inc	70.78%
BCAB	Bioatla Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	13.28%
APLS	Apellis Pharmaceuticals, Inc.	89.81%
CGEM	Cullinan Therapeutics, Inc.	7775.20%
RCUS	Arcus Biosciences, Inc.	7775.20%
MRNA	Moderna, Inc.	70.32%
RVMD	Revolution Medicines, Inc.	7775.20%
SGMO	Sangamo Therapeutics Inc	7775.20%
FOLD	Amicus Therapeutics Inc	88.50%
IMGN	ImmunoGen Inc	99.82%
IGMS	IGM Biosciences LLC	7775.20%
AMTI	Applied Molecular Transport Inc.	7775.20%
BLUE	Genetix Biotherapeutics Inc	-6.65%
GILD	Gilead Sciences, Inc.	78.84%